|
ARHGEF35 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.676200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.698600E-01 |
| Normal-vs-Stage2 |
1.674800E-01 |
| Normal-vs-Stage3 |
7.728400E-01 |
| Normal-vs-Stage4 |
4.981400E-01 |
| Stage1-vs-Stage2 |
2.752400E-01 |
| Stage1-vs-Stage3 |
6.806200E-01 |
| Stage1-vs-Stage4 |
4.634200E-01 |
| Stage2-vs-Stage3 |
5.353200E-01 |
| Stage2-vs-Stage4 |
9.508000E-01 |
| Stage3-vs-Stage4 |
7.117600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.451600E-01 |
| Normal-vs-AfricanAmerican |
6.685400E-01 |
| Normal-vs-Asian |
1.525450E-01 |
| Caucasian-vs-AfricanAmerican |
3.693400E-01 |
| Caucasian-vs-Asian |
3.721400E-01 |
| AfricanAmerican-vs-Asian |
3.756400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.019200E-01 |
| Normal-vs-Female |
4.008200E-01 |
| Male-vs-Female |
4.163800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.541580E-01 |
| Normal-vs-Extreme_Weight |
8.723000E-01 |
| Normal-vs-Obese |
2.801800E-01 |
| Normal-vs-Extreme_Obese |
8.451200E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.376000E-01 |
| Normal_Weight-vs-Obese |
3.504400E-02 |
| Normal_Weight-vs-Extreme_Obese |
3.559600E-01 |
| Extreme_Weight-vs-Obese |
2.610400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.777200E-01 |
| Obese-vs-Extreme_Obese |
7.786000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.331200E-01 |
| Normal-vs-Age(41-60Yrs) |
2.249400E-01 |
| Normal-vs-Age(61-80Yrs) |
3.777400E-01 |
| Normal-vs-Age(81-100Yrs) |
3.605000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.620400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.720600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.250200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.425900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.947640E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.515600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.489820E-01 |
| Normal-VS-Type2 PRCC |
2.400000E-02 |
| Normal-VS-KIRP CIMP |
1.110610E-01 |
| Normal-VS-Unclassified PRCC |
7.632000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.013800E-04 |
| Type1 PRCC-VS-KIRP CIMP |
7.545500E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.294800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.382200E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
4.903500E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.893900E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.883800E-02 |
| Normal-vs-N1 |
7.710400E-01 |
| Normal-vs-N2 |
7.166000E-01 |
| N0-vs-N1 |
1.732590E-01 |
| N0-vs-N2 |
9.341200E-01 |
| N1-vs-N2 |
6.083800E-01 |
|
|
